Related Experiment Video

Updated: Jun 27, 2025

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.5K

Are FGFR Fusions and Mutations the Next Tumor-Agnostic Targets in Oncology?

Haley Ellis1, Lipika Goyal2

  • 1Division of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

JCO Precision Oncology
|May 6, 2024
PubMed

Insights

Two NCI-MATCH trials evaluated erdafitinib for fibroblast growth factor receptor (FGFR)-altered cancers. These tumor-agnostic studies represent key advancements in precision oncology for targeted therapies.

Area of Science:

  • Oncology
  • Genetics
  • Clinical Trials

Background:

  • The NCI-MATCH trial is a precision medicine study evaluating targeted therapies in patients with tumors harboring specific genetic alterations.
  • Erdafitinib is an oral inhibitor targeting fibroblast growth factor receptors (FGFRs), which are implicated in various cancers.

Discussion:

  • This research presents findings from two NCI-MATCH tumor-agnostic sub-studies (Arm J and Arm K) that investigated erdafitinib in patients with FGFR-altered solid tumors.
  • The trials assessed the efficacy and safety of erdafitinib across diverse cancer types, irrespective of their tissue of origin, highlighting a novel approach to cancer treatment.

Key Insights:

  • Erdafitinib demonstrated activity in patients with FGFR-altered cancers, supporting its potential as a targeted therapy.
  • The tumor-agnostic design of these trials allows for broader patient access to investigational drugs based on molecular alterations rather than cancer type.

Outlook:

  • These trials serve as crucial steppingstones, paving the way for future precision oncology initiatives and the development of FGFR-targeted agents.
  • Further research may explore optimal patient selection strategies and combination therapies to maximize the benefit of erdafitinib in FGFR-altered malignancies.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K